SCHEMBL23976308

SCHEMBL23976308

COC(=O)C(C)CCC(C)(C)N

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GRM4 Q14833 1/20 0.33
CA14 Q9ULX7 3/20 0.32
TSHR P16473 2/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
NFKB1 P19838 1/20 0.32
ADRA1A P35348 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ZDHHC7 Q9NXF8 1/20 0.32
CA12 O43570 2/20 0.31
ALDH1A1 P00352 2/20 0.31
GABRR1 P24046 2/20 0.30
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25763777 0.84 CA1 (0.40) CA1CA2
SCHEMBL18124774 0.80 CA1 (0.41) CA1CA2SMN1; SMN2CA14ZDHHC7
Hydrochloric Acid SCHEMBL20303949 0.80 CA1 (0.37) CA1CA2SMN1; SMN2GRM4ZDHHC7
SCHEMBL14459291 0.79 SMN1; SMN2 (0.37) CA1CA2SMN1; SMN2CA14TSHR
SCHEMBL26385278 0.79 SMN1; SMN2 (0.37) CA1CA2SMN1; SMN2CA14TSHR
SCHEMBL20126571 0.78 CA1 (0.36) CA1CA2SMN1; SMN2CA14LMNA
SCHEMBL21704813 0.78 CA1 (0.33) CA1CA2SMN1; SMN2GABRR1
SCHEMBL7105090 0.78 SMN1; SMN2 (0.46) CA1CA2SMN1; SMN2CA14TSHR
SCHEMBL17308180 0.78 SMN1; SMN2 (0.38) CA1CA2SMN1; SMN2CA14ZDHHC7
SCHEMBL18232696 0.78 CA1 (0.42) CA1CA2SMN1; SMN2CA14LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222363-A1 CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed